BI

BVF Inc Portfolio holdings

AUM $2.8B
This Quarter Return
+7.17%
1 Year Return
+17.96%
3 Year Return
+404.14%
5 Year Return
+563.41%
10 Year Return
+5,885.83%
AUM
$1.84B
AUM Growth
+$1.84B
Cap. Flow
+$223M
Cap. Flow %
12.13%
Top 10 Hldgs %
45.79%
Holding
65
New
8
Increased
22
Reduced
13
Closed
3

Top Buys

1
RLAY icon
Relay Therapeutics
RLAY
$144M
2
KYMR icon
Kymera Therapeutics
KYMR
$85M
3
CYTK icon
Cytokinetics
CYTK
$71.9M
4
RVMD icon
Revolution Medicines
RVMD
$45.3M
5
RPTX icon
Repare Therapeutics
RPTX
$34.5M

Top Sells

1
PRNB
Principia Biopharma Inc. Common Stock
PRNB
$88.8M
2
ARGX icon
argenx
ARGX
$57.9M
3
KURA icon
Kura Oncology
KURA
$39.4M
4
IONS icon
Ionis Pharmaceuticals
IONS
$32.6M
5
BDTX icon
Black Diamond Therapeutics
BDTX
$16M

Sector Composition

1 Healthcare 98.4%
Name Market Value Portfolio Weight Shares or Principal Shares
Change % 		Capital Flow
CTMX icon
26
CytomX Therapeutics
CTMX
$351M
$23.7M 1.29%
3,559,722
+444,185
+14% +$2.95M
MTEM
27
DELISTED
Molecular Templates, Inc.
MTEM
$23.5M 1.28%
2,149,057
– –
CBIO
28
Crescent Biopharma, Inc. Common Stock
CBIO
$185M
$22.2M 1.21%
7,244,262
– –
RNAC icon
29
Cartesian Therapeutics
RNAC
$263M
$21M 1.14%
8,459,547
+165,000
+2% +$409K
OVID icon
30
Ovid Therapeutics
OVID
$90.3M
$20.8M 1.13%
3,622,051
+1,229,900
+51% +$7.06M
EPIX icon
31
ESSA Pharma
EPIX
$11.2M
$20.7M 1.13%
3,005,589
+1,020,700
+51% +$7.04M
INFI
32
DELISTED
Infinity Pharmaceuticals, Inc.
INFI
$20.4M 1.11%
17,426,968
– –
ANAB icon
33
AnaptysBio
ANAB
$599M
$18.1M 0.99%
1,227,405
-66,996
-5% -$988K
CALT
34
DELISTED
Calliditas Therapeutics AB American Depositary Shares
CALT
$18M 0.98%
750,000
– –
CALA
35
DELISTED
Calithera Biosciences, Inc
CALA
$15.8M 0.86%
4,585,638
-2,505,000
-35% -$8.64M
SPRO icon
36
Spero Therapeutics
SPRO
$119M
$15M 0.82%
1,344,334
+857,794
+176% +$9.57M
CTIC
37
DELISTED
CTI BioPharma Corp. (DE) Common Stock
CTIC
$14.9M 0.81%
6,929,690
– –
PNT
38
DELISTED
POINT Biopharma Global Inc. Common Stock
PNT
$14.4M 0.78%
+1,000,000
New +$14.4M
VSTM icon
39
Verastem
VSTM
$575M
$13M 0.71%
10,747,994
+5,719,000
+114% +$6.92M
MEIP icon
40
MEI Pharma
MEIP
$151M
$12.7M 0.69%
4,080,162
-50,000
-1% -$156K
PHAT icon
41
Phathom Pharmaceuticals
PHAT
$841M
$11.8M 0.64%
322,098
– –
PVLA
42
Palvella Therapeutics, Inc. Common Stock
PVLA
$579M
$11.4M 0.62%
5,494,582
+2,379,200
+76% +$4.93M
CDTX icon
43
Cidara Therapeutics
CDTX
$1.61B
$10.7M 0.58%
3,766,704
+77,501
+2% +$221K
PANA.U
44
DELISTED
Panacea Acquisition Corp. Units, each consisting of one share of Class A common stock and one-third
PANA.U
$9.6M 0.52%
+800,000
New +$9.6M
GNCA
45
DELISTED
Genocea Biosciences, Inc.
GNCA
$9.19M 0.5%
4,012,404
+1,994,006
+99% +$4.57M
GMDA
46
DELISTED
Gamida Cell Ltd. Ordinary Shares
GMDA
$8.9M 0.48%
2,143,667
– –
CFRX
47
DELISTED
ContraFect Corporation
CFRX
$8.45M 0.46%
1,600,000
– –
TNGX icon
48
Tango Therapeutics
TNGX
$727M
$8.29M 0.45%
+800,000
New +$8.29M
CRVS icon
49
Corvus Pharmaceuticals
CRVS
$431M
$6.99M 0.38%
1,743,712
+1,600
+0.1% +$6.42K
EVLO
50
DELISTED
Evelo Biosciences, Inc. Common Stock
EVLO
$6.85M 0.37%
1,300,000
– –
1
2
3